July 5, 2019
Tilray® Expands European Leadership Team with Five Senior Appointments
Tilray expands European leadership team
Pharmaceuticals, Biotechnology and Life Sciences
Category: Regions
July 5, 2019
ACT Genomics Opens Third Laboratory in Asia at Hong Kong Science Park
Strives to Change the Cancer Treatment Model in Hong Kong Ready to Tap Tremendous Opportunities in Greater Bay Area HONG…
July 3, 2019
2019 Hansen Family Award goes to Professor Edith Heard
The award-winner of the 2019 Hansen Family Award is Professor Edith Heard. The Board of Trustees of the Bayer Science & Education Foundation and the Scientific Committee for this award have presented her with one of Germany’s most prestigious scientific accolades including a prize money of EUR 75,000.
July 3, 2019
ULTOMIRIS® (ravulizumab) Receives Marketing Authorization from European Commission for Adults with Paroxysmal Nocturnal Hemoglobinuria (PNH)
– ULTOMIRIS has the potential to become the new standard of care for both complement inhibitor-naïve patients and patients switching from SOLIRIS® (eculizumab) –
July 3, 2019
Takeda to Demonstrate Global Leadership in Hematology at ISTH 2019
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”), the global biotechnology leader in rare diseases, will present research covering a broad range of rare bleeding disorders at the 27th Annual International Society on Thrombosis and Haemostasis Congress
July 3, 2019
Dr. Reddy’s Laboratories Announces First-to-market Launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial in the U.S. Market
Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate® injection, 250 mcg/mL, approved by the U.S. Food and Drug Administration (USFDA).
July 3, 2019
Citryll Completes First Closing of a € 15M Series A to Develop its NETosis Inhibiting Antibody
OSS, Netherlands–(BUSINESS WIRE)–http://www.citryll.com/ announced today the first closing of a targeted € 15 million investment round, funded by ModiQuest B.V.,…
July 3, 2019
BIOCORP Enters Exclusive Negotiations With SANOFI to Use Their MallyaTM Connected Device With Sanofi’s Integrated Diabetes Care Platform
Eligible PEA PME) (Paris:ALCOR), a French company specializing in the development and manufacturing of medical devices and smart drug delivery systems, announces that they have entered into an exclusive negotiation with SANOFI, a worldwide leader within the pharmaceutical industry, aimed at introducing their Mallya connected device into SANOFI’s integrated diabetes care platform.
July 2, 2019
EnPro Industries Announces Acquisition of The Aseptic Group
EnPro Industries, Inc. (NYSE: NPO), a leading manufacturer of engineered industrial products, today announced it has acquired The Aseptic Group (comprising Aseptic Process Equipment SAS and Aseptic Services SARL), a privately-held company which distributes, designs and manufactures aseptic fluid transfer products for the pharmaceutical and biopharmaceutical industries.
July 2, 2019
Novocure to Report Second Quarter 2019 Financial Results
Novocure announced today that it will report financial results for the second quarter 2019 on Thursday, July 25, 2019, before the U.S. financial markets open.